Furthermore, anti-BCMA antibody was detected after successful donor lymphocyte infusion in relapsed MM patients after allogeneic stem cell transplant, suggesting BCMA as a target of donor B-cell immunity [55]. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.